Swiss National Bank Buys 2,800 Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)

Swiss National Bank boosted its position in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 1.8% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 155,652 shares of the biopharmaceutical company’s stock after buying an additional 2,800 shares during the period. Swiss […]

Leave a Reply

Your email address will not be published.

Previous post D.R. Horton, Inc. (NYSE:DHI) Receives $148.65 Average Price Target from Analysts
Next post Swiss National Bank Purchases 300 Shares of Piper Sandler Companies (NYSE:PIPR)